Ontology highlight
ABSTRACT:
SUBMITTER: Al Badarin FJ
PROVIDER: S-EPMC2665981 | biostudies-other | 2009 Apr
REPOSITORIES: biostudies-other
Al Badarin Firas J FJ Kullo Iftikhar J IJ Kopecky Stephen L SL Thomas Randal J RJ
Mayo Clinic proceedings 20090401 4
Ezetimibe is a new lipid-lowering agent that inhibits intestinal absorption of dietary cholesterol. It substantially lowers low-density lipoprotein cholesterol levels when used alone or in combination with statins. However, its effect on cardiovascular mortality remains unknown. We reviewed peer-reviewed published literature on the effect of ezetimibe on different phases of atherosclerosis. MEDLINE, EMBASE, BIOSIS, and other Web of Knowledge databases were searched for relevant abstracts and art ...[more]